Jennifer G. Wilson

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

Jennifer G. Wilson, Kathleen D. Liu, Hanjing Zhuo et al. · The Lancet Respiratory Medicine · 2014 · 782 citations · Full text

Regenerative Medicine, Cell Therapy, Stem Cells +9

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde, Wesley H. Self, Katherine Adams et al. · JAMA · 2021 · 671 citations · Full text

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring, Mark W. Tenforde, James D. Chappell et al. · BMJ · 2022 · 666 citations · Full text

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial

Michael A. Matthay, Carolyn S. Calfee, Hanjing Zhuo et al. · The Lancet Respiratory Medicine · 2018 · 612 citations · Full text

Acute Lung Injury, Respiratory Distress Syndrome (Pulmonary Critical Care), Randomised Phase 2A +9

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Mark W. Tenforde, Samantha M. Olson, Wesley H. Self et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 319 citations · Full text